Litcius/Paper detail

Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection

Jacqueline Dinnes, Jonathan J Deeks, Sarah Berhane, Melissa Taylor, Ada Adriano, Clare Davenport, Sabine Dittrich, Devy Emperador, Yemisi Takwoingi, Jane Cunningham, Sophie Beese, Julie Domen, Janine Dretzke, Lavinia Ferrante di Ruffano, Isobel Marion Harris, Malcolm J Price, Sian Taylor‐Phillips, Lotty Hooft, Mariska Leeflang, Matthew D. F. McInnes, René Spijker, Ann Van den Bruel, Cochrane COVID-19 Diagnostic Test Accuracy Group

2021Cochrane Database of Systematic Reviews626 citationsDOIOpen Access PDF

Abstract

Accurate rapid diagnostic tests for SARS-CoV-2 infection could contribute to clinical and public health strategies to manage the COVID-19 pandemic. Point-of-care antigen and molecular tests to detect current infection could increase access to testing and early confirmation of cases, and expediate clinical and public health management decisions that may reduce transmission.

Topics & Concepts

MedicinePoint of carePoint-of-care testingPandemicAsymptomaticPublic healthPopulationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Health careTransmission (telecommunications)Coronavirus disease 2019 (COVID-19)Intensive care medicineVirologyImmunologyDiseasePathologyEnvironmental healthInfectious disease (medical specialty)Computer scienceEconomic growthEconomicsTelecommunicationsSARS-CoV-2 detection and testingBiosensors and Analytical DetectionSARS-CoV-2 and COVID-19 Research